CV Sciences Files Q1 2025 10-Q
Ticker: CVSI · Form: 10-Q · Filed: May 14, 2025 · CIK: 1510964
| Field | Detail |
|---|---|
| Company | Cv Sciences, Inc. (CVSI) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, SEC filing
TL;DR
CV Sciences Q1 2025 10-Q is in. Check financials and stock option details.
AI Summary
CV Sciences, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as CannaVEST Corp., reported on its financial performance and business operations. Key financial data points and disclosures related to stock options and warrants are included in this filing.
Why It Matters
This filing provides investors with an update on CV Sciences' financial health and operational status for the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — The filing contains standard financial disclosures, but the nature of the pharmaceutical preparations industry and potential product concentration risks warrant a medium risk assessment.
Key Numbers
- 2025-03-31 — Period End Date (The 10-Q covers financial results up to this date.)
- 2025-05-14 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2024-03-31 — Prior Year Quarter End (Used for comparative financial analysis.)
Key Players & Entities
- CV Sciences, Inc. (company) — Filer of the 10-Q
- CannaVEST Corp. (company) — Former name of CV Sciences, Inc.
- 20250331 (date) — Period of report for the 10-Q
- 20250514 (date) — Filing date of the 10-Q
- 0001510964 (company) — Central Index Key for CV Sciences, Inc.
FAQ
What is the reporting period for this 10-Q filing?
The 10-Q filing is for the period ending March 31, 2025.
What was CV Sciences, Inc. formerly known as?
CV Sciences, Inc. was formerly known as CannaVEST Corp., with a name change effective February 5, 2013.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 14, 2025.
Does the filing mention any specific product categories contributing to revenue?
Yes, the filing references 'Retail Natural Products and Other' and 'Elevated Softgels' in the context of sales revenue net.
Are there any disclosures related to stock options or warrants?
Yes, the filing includes information on 'Employee Stock Option' and 'Warrants with 0.00875 Exercise Price'.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding CV Sciences, Inc. (CVSI).